Midostaurin

Indicated in combination with an aromatase inhibitor for the treatment of pre/perimenopausal or postmenopausal women, with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer, as initial endocrine-based therapy; or fulvestrant ...

Indicated in the palliative treatment of advanced prostatic cancer.

Indicated in adults for the treatment of irritable bowel syndrome with constipation (IBS-C), chronic idiopathic constipation (CIC)

Indicated as an adjunct to diet and exercise to improve glycemic control in patients 10 years and older with type 2   diabetes mellitus,  to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial   infarction, or non-fat...

Indicated for the treatment of patients two years of age and older with gastrointestinal infections caused by Ancylostoma duodenale (hookworm), Ascaris lumbricoides (roundworm), Enterobius vermicularis (pinworm), Necator americanus (hookworm), and Trichuris trichiura (whipworm).

Indicated for the treatment of symptomatic orthostatic hypotension (OH).

Indicated for treatment of Idiopathic Pulmonary Fibrosis,  Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype, Systemic Sclerosis-Associated Interstitial Lung Disease

Indicated for the treatment of adult and pediatric patients with hereditary tyrosinemia type 1 (HT-1) in combination with dietary restriction of tyrosine and phenylalanine.

Indicated for the treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid (UDCA) in adults with an inadequate response to UDCA, or as monotherapy in adults unable to tolerate UDCA.

Indicated for treatment of Acromegaly, Carcinoid Tumors, VIP-secreting tumors.

For the temporary relief of symptoms of food cravings, including: constant appetite, increased or insatiable hunger. The peripheral actions of oxytocin mainly reflect secretion from the pituitary gland.
Purity not les sthan 99% Complete impurity characterization available

Indium In-111 pentetreotide is an agent for the scintigraphic localization of primary and metastatic neuroendocrine tumors bearing somatostatin receptors.